KFG Wealth Management LLC Has $283,000 Stake in iShares Biotechnology ETF (NASDAQ:IBB)

KFG Wealth Management LLC increased its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 8.5% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 2,143 shares of the financial services provider’s stock after purchasing an additional 168 shares during the quarter. KFG Wealth Management LLC’s holdings in iShares Biotechnology ETF were worth $283,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of the business. SPC Financial Inc. raised its stake in shares of iShares Biotechnology ETF by 2.4% during the third quarter. SPC Financial Inc. now owns 3,265 shares of the financial services provider’s stock worth $475,000 after buying an additional 75 shares during the last quarter. Werba Rubin Papier Wealth Management increased its stake in iShares Biotechnology ETF by 2.7% in the third quarter. Werba Rubin Papier Wealth Management now owns 2,918 shares of the financial services provider’s stock valued at $425,000 after purchasing an additional 76 shares in the last quarter. Capital Investment Advisors LLC increased its stake in iShares Biotechnology ETF by 1.0% in the fourth quarter. Capital Investment Advisors LLC now owns 10,449 shares of the financial services provider’s stock valued at $1,381,000 after purchasing an additional 99 shares in the last quarter. Magnus Financial Group LLC increased its stake in iShares Biotechnology ETF by 0.8% in the fourth quarter. Magnus Financial Group LLC now owns 12,967 shares of the financial services provider’s stock valued at $1,714,000 after purchasing an additional 104 shares in the last quarter. Finally, Daiwa Securities Group Inc. increased its stake in iShares Biotechnology ETF by 12.0% in the third quarter. Daiwa Securities Group Inc. now owns 1,028 shares of the financial services provider’s stock valued at $150,000 after purchasing an additional 110 shares in the last quarter. 62.45% of the stock is owned by institutional investors.

iShares Biotechnology ETF Stock Down 0.7 %

Shares of NASDAQ:IBB opened at $137.30 on Monday. iShares Biotechnology ETF has a 52 week low of $123.60 and a 52 week high of $150.57. The company has a 50 day moving average price of $136.04 and a two-hundred day moving average price of $141.81.

iShares Biotechnology ETF Cuts Dividend

The company also recently announced a dividend, which was paid on Friday, December 20th. Shareholders of record on Tuesday, December 17th were paid a $0.0624 dividend. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.